Direct-to-physician marketing: is it true?

20 March 2006

A study undergoing open peer-review in the USA has looked into the degree to which drug companies' marketing materials directed at physicians are truthful and useful.

In the overwhelming majority of cases (75%), the authors of the report - published in Biomed Central's Family Practice - found that the claims made by companies were valid. The main complaint that researchers Roberto Cardarelli, John Licciardone and Lockwood Taylor had to make was that three of the brochures studied (out of 20), presented data that was different from that in the original published study.

Nevertheless, the authors conclude that doctors should use critical judgement about using marketing materials alone before prescribing a medication.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight